A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

R Hájek, T Masszi, MT Petrucci, A Palumbo, L Rosiñol… - Leukemia, 2017 - nature.com
… a phase II study in heavily pretreated patients. That study and other phase II studies further
… Here we present the results of the randomized phase III study PX-171-011 (FOCUS), which …

Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer …

E Laack, N Dickgreber, T Muller, A Knuth… - Journal of clinical …, 2004 - ascopubs.org
… The MILES results contrast with those of a smaller randomized study that compared …
Thus, we conducted a multicenter randomized phase III trial to evaluate whether cisplatin-…

Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results

G Mantovani, A Macciò, C Madeddu, G Gramignano… - Nutrition, 2008 - Elsevier
… With regard to the present phase III study, we report the interim results on 125 patients
enrolled up to now. The safety data did not show any side effect due to anticachectic treatment …

[PDF][PDF] Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: a randomized phase III study (ALLY‐3+)

V Leroy, P Angus, JP Bronowicki, GJ Dore… - …, 2016 - Wiley Online Library
… To this end, we report herein the results of a phase III randomized study (ALLY-31) evaluating
the efficacy and safety of the combination of DCV-SOF plus RBV (DCV-SOF-RBV) for 12 or …

[HTML][HTML] Updated efficacy analysis including secondary population results for OAK: a randomized phase III study of atezolizumab versus docetaxel in patients with …

L Fehrenbacher, J von Pawel, K Park… - Journal of thoracic …, 2018 - Elsevier
… OAK (NCT02008227) is a randomized phase III study comparing the efficacy and safety of
… However, after the randomized phase II POPLAR study demonstrated survival benefit with …

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

J Vansteenkiste, R Pirker, B Massuti… - Journal of the …, 2002 - academic.oup.com
… This placebo-controlled, double-blind, randomized phase III study tested the safety and
efficacy of darbepoetin alfa administered weekly for the treatment of anemia in patients with lung …

Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.

A Du Bois, J Sehouli, I Vergote, G Ferron, A Reuss… - 2020 - ascopubs.org
6000 Background: The role of secondary cytoreductive surgery in recurrent ovarian cancer (ROC)
has been under debate for decades. A recent trial in unselected patients (pts) failed to …

[HTML][HTML] A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung …

P Zatloukal, F Cardenal, A Szczesna, V Gorbunova… - Annals of oncology, 2010 - Elsevier
… Overall survival is the time from randomization until death. In this study, TtP is defined as
the time from randomization to date of first documentation of radiologic progression or death …

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer

M Peeters, KS Oliner, A Parker, S Siena… - Clinical Cancer …, 2013 - AACR
… This analysis included patients enrolled in the panitumumab plus BSC arm of the randomized
phase III study and in the open-label extension study. The analysis was conducted for …

Design issues in randomized phase II/III trials

EL Korn, B Freidlin, JS Abrams… - Journal of Clinical …, 2012 - ascopubs.org
… The treatments prioritized in a phase II trial are then tested definitively against a control
treatment in a randomized phase III trial. Randomized phase II/III trials use an adaptive trial …